Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Income (2018 - 2025)

Historic Net Income for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.

  • Neurogene's Net Income fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
  • As of Q3 2025, Neurogene's Net Income stood at -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Net Income peaked at -$11.9 million during Q2 2023, and registered a low of -$23.2 million during Q2 2025.
  • Moreover, its 3-year median value for Net Income was -$18.6 million (2024), whereas its average is -$17.8 million.
  • As far as peak fluctuations go, Neurogene's Net Income tumbled by 5713.92% in 2024, and later crashed by 365.48% in 2025.
  • Over the past 3 years, Neurogene's Net Income (Quarter) stood at -$14.0 million in 2023, then plummeted by 40.71% to -$19.7 million in 2024, then dropped by 7.35% to -$21.1 million in 2025.
  • Its Net Income was -$21.1 million in Q3 2025, compared to -$23.2 million in Q2 2025 and -$22.8 million in Q1 2025.